Viridian Therapeutics, Inc.\DE (VRDN) Interest Coverage Ratio (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 33.56 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 80.34% year-over-year to 33.56; the TTM figure through Mar 2026 stood at 47.28 (up 76.33% YoY), while the FY2025 annual figure was 1.15, up 20.02% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 33.56, up from 34.23 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 7009.43 in Q4 2022, with the low at 624.8 in Q4 2024.
• The 5-year median for Interest Coverage Ratio is 103.14 (2024), against an average of 287.14.
• The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio soared 4920.62% in 2022, then sank 1228.72% in 2025.
• Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio stood at 7009.43 in 2022, then tumbled by 102.55% to 178.7 in 2023, then tumbled by 249.65% to 624.8 in 2024, then jumped by 94.52% to 34.23 in 2025, then gained by 1.97% to 33.56 in 2026.
• Business Quant data shows VRDN's Interest Coverage Ratio at 33.56 in Q1 2026, 34.23 in Q4 2025, and 71.45 in Q3 2025.